Thermo Fisher Q1 revenue $11.82B (+19%), adjusted EPS $7.25; raises dividend 15%

THERMO FISHER SCIENTIFIC INC.

2022-Q1 EPS reported $5.61 revenue$11,818,000,000

GAAP EPS $5.61 vs $5.88 last year; adjusted EPS $7.25 vs $7.21.
Core organic growth 16%; COVID-19 testing revenue $1.68B.
Repurchased $2.0B of stock and increased dividend by 15%.
PPD clinical research business integration proceeding smoothly.
Moderna entered 15-year strategic collaboration for mRNA manufacturing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.